HEMELI Trademark

Trademark Overview

On Thursday, May 19, 2011, a trademark application was filed for HEMELI with the United States Patent and Trademark Office. The USPTO has given the HEMELI trademark a serial number of 79098529. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, May 20, 2021. This trademark is owned by PIERRE FABRE DERMATOLOGIE. The HEMELI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely, medicines for treating hemangioma
hemeli

General Information

Serial Number79098529
Word MarkHEMELI
Filing DateThursday, May 19, 2011
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, May 20, 2021
Registration Number4075898
Registration DateTuesday, December 27, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 11, 2011

Trademark Statements

Goods and ServicesPharmaceutical products, namely, medicines for treating hemangioma

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, August 3, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePIERRE FABRE DERMATOLOGIE
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR
Party NamePIERRE FABRE DERMATOLOGIE
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR
Party NamePIERRE FABRE DERMATOLOGIE
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events

Event DateEvent Description
Sunday, December 5, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Sunday, December 5, 2021DEATH OF INTERNATIONAL REGISTRATION
Friday, May 17, 2019TOTAL INVALIDATION PROCESSED BY THE IB
Monday, April 15, 2019TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, April 15, 2019INVALIDATION PROCESSED
Wednesday, April 3, 2019TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, August 3, 2018CANCELLED SECTION 71
Friday, May 11, 2012NOTIFICATION PROCESSED BY IB
Sunday, February 12, 2012NOTIFICATION PROCESSED BY IB
Wednesday, February 8, 2012FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, February 8, 2012FINAL DISPOSITION PROCESSED
Thursday, January 26, 2012GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, December 27, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, October 11, 2011PUBLISHED FOR OPPOSITION
Wednesday, September 21, 2011NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 21, 2011NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 21, 2011NOTICE OF PUBLICATION
Thursday, September 8, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 7, 2011ASSIGNED TO EXAMINER
Saturday, July 16, 2011APPLICATION FILING RECEIPT MAILED
Tuesday, July 12, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, July 11, 2011LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, July 7, 2011SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

hemeli treating hemangioma medicines namely products pharmaceutical